Cargando…

Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial

Folic acid (FA) supplementation prevents neural tube defects (NTDs), but the effects on other reproductive outcomes are unclear. While common recommendation is 0.4 mg/day in addition to regular nutrition, the most appropriate dose of FA is still under debate. We investigated the effects of a higher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortolus, Renata, Filippini, Francesca, Cipriani, Sonia, Trevisanuto, Daniele, Cavallin, Francesco, Zanconato, Giovanni, Somigliana, Edgardo, Cesari, Elena, Mastroiacovo, Pierpaolo, Parazzini, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704306/ https://www.ncbi.nlm.nih.gov/pubmed/34959975 http://dx.doi.org/10.3390/nu13124422

Ejemplares similares

Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands
por: Bortolus, Renata, et al.
Publicado: (2014)

Influence of Solution Treatment Time on Precipitation Behavior and Mechanical Properties of Mg-2.0Nd-2.0Sm-0.4Zn-0.4Zr Alloy
por: Ma, Tao, et al.
Publicado: (2021)

The Amount of Folic Acid in Weekly Iron-Folic Acid Supplements Should Be Increased From 0.4 to 2,8 mg to Reduce Neural Tube Defects (NTD)
por: Samson, Kaitlyn, et al.
Publicado: (2022)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
por: Glockler, Antonia, et al.
Publicado: (2020)

Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis
por: Nash, Peter, et al.
Publicado: (2016)

Weekly iron–folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia
por: Samson, Kaitlyn L I, et al.
Publicado: (2020)

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers
por: Ban, Mu Seong, et al.
Publicado: (2020)

Effect of Isothermal Repetitive Upsetting Extrusion on the Microstructure of Mg-12.0Gd-4.5Y-2.0Zn-0.4Zr Alloy
por: Zhang, Guanshi, et al.
Publicado: (2018)

Beneficial Effect of Increasing the Dose of Tamsulosin to 0.4 mg in Japanese Patients with Benign Prostatic Hyperplasia
por: Hirose, Yasuhiko, et al.
Publicado: (2011)

Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
por: Kang, Tae Wook, et al.
Publicado: (2021)

In vitro degradation, haemolysis and cytotoxicity study of Mg‐0.4Ce/ZnO(2) nanocomposites
por: Prabakaran, Meenachi, et al.
Publicado: (2021)

Microstructure and Low-Cycle Fatigue Behavior of Al-9Si-4Cu-0.4Mg-0.3Sc Alloy with Different Casting States
por: Wang, Guanyi, et al.
Publicado: (2020)

An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg
por: Pratley, Richard E., et al.
Publicado: (2021)

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
por: Kim, Su Jin, et al.
Publicado: (2017)

In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study
por: Ibach, Mitchel J, et al.
Publicado: (2022)

Magnesium Deintercalation From the Spinel‐Type MgMn(2‐y)Fe(y)O(4) (0.4≤y≤2.0) by Acid‐Treatment and Electrochemistry
por: Medina, Alejandro, et al.
Publicado: (2021)

Zn(0.4)Mg(0.6)Fe(2)O(4) nanoenzyme: a novel chemo-sensitizer for the chemotherapy treatment of oral squamous cell carcinoma
por: Chen, Liang, et al.
Publicado: (2022)

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Effect of the Ca(2)Mg(6)Zn(3) Phase on the Corrosion Behavior of Biodegradable Mg-4.0Zn-0.2Mn-xCa Alloys in Hank’s Solution
por: Fu, Junjian, et al.
Publicado: (2022)

Dipole Relaxation in Semiconducting Zn(2−x)Mg(x)InV(3)O(11) Materials (Where x = 0.0, 0.4, 1.0, 1.6, and 2.0)
por: Groń, Tadeusz, et al.
Publicado: (2020)

Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
por: Davidson, Antonia, et al.
Publicado: (2021)

Ni(0.6)Zn(0.4)O Synthesised via a Solid-State Method for Promoting Hydrogen Sorption from MgH(2)
por: Sazelee, Noratiqah, et al.
Publicado: (2023)

Ciprofloxacin Release and Corrosion Behaviour of a Hybrid PEO/PCL Coating on Mg3Zn0.4Ca Alloy
por: Moreno, Lara, et al.
Publicado: (2023)

Effect of Heat Treatment on the Dry Sliding Wear Behavior of the Mg-3Zn-0.4Ca Alloy for Biodegradable Implants
por: Pulido-González, Nuria, et al.
Publicado: (2023)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
por: Sebastianelli, Arcangelo, et al.
Publicado: (2019)

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
por: Ahn, Sun Tae, et al.
Publicado: (2020)

Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Tae, Bum Sik, et al.
Publicado: (2017)

The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Kim, Su Jin, et al.
Publicado: (2017)

Tunable Microwave Dielectric Properties of Ca(0.6)La(0.8/3)TiO(3) and Ca(0.8)Sm(0.4/3)TiO(3)-Modified (Mg(0.6)Zn(0.4))(0.95)Ni(0.05)TiO(3) Ceramics with a Near-Zero Temperature Coefficient
por: Pan, Chung-Long, et al.
Publicado: (2021)

Enhanced thermoelectric properties in N-type Mg(2)Si(0.4−x)Sn(0.6)Sb(x) synthesized by alkaline earth metal reduction
por: Chen, Jin, et al.
Publicado: (2019)

Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30mg and 20 mg with epinefrine 1 mg%) in medically compromised cardiac patients: A cross-over, randomized, single blinded study
por: Torres-Lagares, Daniel, et al.
Publicado: (2012)

Immobilization and property of penicillin G acylase on amino functionalized magnetic Ni(0.3)Mg(0.4)Zn(0.3)Fe(2)O(4) nanoparticles prepared via the rapid combustion process
por: Ma, Mingyi, et al.
Publicado: (2023)

Li(0.5)Al(0.5)Mg(2)(MoO(4))(3)
por: Ennajeh, Ines, et al.
Publicado: (2013)

A Supernova Search At Z = 0.2 - 0.4
por: Hardin, D
Publicado: (2000)

Enhancing the Corrosion Resistance Performance of Mg-1.8Zn-1.74Gd-0.5Y-0.4Zr Biomaterial via Solution Treatment Process
por: Liu, Ya, et al.
Publicado: (2020)

A DFT study on nanocones, nanotubes (4,0), nanosheets and fullerene C(60) as anodes in Mg-ion batteries
por: Vessally, Esmail, et al.
Publicado: (2019)

Folic Acid Supplementation and Preterm Birth: Results from Observational Studies
por: Mantovani, Elena, et al.
Publicado: (2014)

Structural, Optical and Electrical Properties of Cu(0.6)Co(x)Zn(0.4−x)Fe(2)O(4) (x = 0.0, 0.1, 0.2, 0.3, 0.4) Soft Ferrites
por: Farooq, W. Aslam, et al.
Publicado: (2021)

High-pressure synthetic (Na(0.97)Mg(0.03))(Mg(0.43)Fe(0.17) (3+)Si(0.40))Si(2)O(6), with six-coordinated silicon, isostructural with P2/n omphacite
por: Posner, Esther S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_oag0u72bl445rgn0uco6v8i9k7